Our response to current COVID-19 pandemic

Our response to current COVID-19 pandemic

Due to the current COVID-19 pandemic, things are changing around us at incredible speed, and at DSA we are adapting our operations and business to keep our employees, clients and community safe. Given that our clients include manufacturers and importers of critical...
Transition to ISO 13485:2016

Transition to ISO 13485:2016

ISO will withdraw ISO 13485:2003 on March 1, 2019, three years after the publication of ISO 13485:2016. All Canadian and Foreign manufacturers of class II, III, and IV medical devices holding licences or applying for new or amended licences must complete the...
Access to Information Requests

Access to Information Requests

The Access to Information (ATI) Act allows Canadians to request copies of files which are within the government’s domain. ATI requests are often used within our industry to request copies of Product Registration Dossiers and even Health Canada Inspection...
Thank you for your referrals!

Thank you for your referrals!

DSA is frequently approached by companies who want to seek us out as potential advertisers. Most are surprised to learn that DSA does not engage in traditional advertising models. We don’t go looking for clients; they find us. While clients find us in a...
Transition to ISO 13485:2016

Update- MI/MCI in Leave-on Cosmetics

In the December 2015 update to the Cosmetic Ingredient Hotlist, a restriction was added to the Methylisothiazolinone/Methylchloroisothiazolinone (MI/MCI) entry. MI/MCI when used in combination is a prohibited substance in leave-on cosmetic products. An implementation...
GMP Document Review Project

GMP Document Review Project

DSA was recently by hired by one of our manufacturing clients in in Asia to determine if their manufacturing documents would meet Health Canada expectations. Health Canada requires that all GMP records are made available in English or French. The first part of the...